| Product Name | MF | CAS | Details |
|---|
| BuChE-IN-6 | C21H26N4O2 | 2003213-07-6 | Details |
| HIF-2α-IN-6 | C15H13F4NO3S | 2755401-07-9 | Details |
| RBM10-8 | C17H36NO5P | 2407372-42-1 | Details |
| TNIK-IN-4 | C20H16FN3O3 | 2754266-04-9 | Details |
| Pantothenate kinase-IN-1 | C21H25N5O | 1024168-48-6 | Details |
| (S)-Baxdrostat | C22H25N3O2 | 1428652-16-7 | Details |
| FAK-IN-8 | C15H9Cl2N3O2S | 1374959-91-7 | Details |
| Anticancer agent 47 | C19H14N2O4S | 2461795-23-1 | Details |
| Carpro-AM1 | C21H18ClN3O | 2499489-76-6 | Details |
| hCAIX/XII-IN-4 | C20H16N2O5 | 1119200-33-7 | Details |
| Antileishmanial agent-9 | C23H26O4 | 2477608-91-4 | Details |
| Gü1303 | C20H22N4O3 | 1043922-53-7 | Details |
| Z164597606 | C20H19N3O4 | 1050587-57-9 | Details |
| PAK4-IN-2 | C18H21ClN6 | 2488706-33-6 | Details |
| IDO1/TDO-IN-1 | C21H16O6 | 2379527-72-5 | Details |
| 5-HT7 agonist 2 | C23H29N3O | 1206846-61-8 | Details |
| CXCR2 antagonist 3 | C17H15FN2O4S | 2647464-92-2 | Details |
| Topoisomerase II inhibitor 3 | C18H20N4O4 | 99140-25-7 | Details |
| α-Glucosidase-IN-20 | C23H21NOS | 420809-56-9 | Details |
| Anabolic agent-1 | C15H22N2O6S | 2439179-74-3 | Details |
| EP3 antagonist 3 | C21H18N2O4 | 1227827-88-4 | Details |
| ARN25068 | C19H18N6S | 2649882-80-2 | Details |
| LDHA/PDKs-IN-1 | C19H21FN2O4 | 2490699-40-4 | Details |
| p53 Activator 2 | C20H21N5O2 | 2338764-89-7 | Details |
| FWM-3 | C16H16N6O2S | 714923-33-8 | Details |
| Cdc7-IN-14 | C18H20N4O2S | 2764866-21-7 | Details |
| MAO-B-IN-12 | C22H30O4 | 2394733-97-0 | Details |
| CO delivery molecule 1 | C23H21NO3 | 1972616-04-8 | Details |
| PDE11-IN-1 | C16H10ClN3O3S | 522652-41-1 | Details |
| HIF-1α-IN-2 | C21H19N3OS | 2762315-06-8 | Details |
| Mt KARI-IN-4 | C13H8FN5O3S2 | 2413974-53-3 | Details |
| Neuraminidase-IN-5 | C19H11NO7 | 2473524-63-7 | Details |
| Colletotrichalactones A | C20H20O6 | 2751633-79-9 | Details |
| PTG-0861 | C15H9F5N2O3 | 2494082-34-5 | Details |
| Antibacterial agent 94 | C21H21FO4 | 1666134-58-2 | Details |
| P163-0892 | C19H20N2O3S | 1574576-45-6 | Details |
| APX2039 | C20H15FN4O2 | 2342606-49-7 | Details |
| MRGPRX4 modulator-1 | C16H13ClF3NO3 | 2492596-61-7 | Details |
| DNA-PK-IN-6 | C19H21N7O | 2711810-41-0 | Details |
| COX-2/5-LOX-IN-3 | C17H16ClN3O2S | 2481484-51-7 | Details |
| PARP1-IN-9 | C18H21N3O5 | 2494000-71-2 | Details |
| BChE-IN-13 | C24H28N2O | 2700896-73-5 | Details |
| DC-CPin7 | C19H22N2O5 | 893781-17-4 | Details |
| MmpL3-IN-1 | C20H21F2N3O | 2290534-93-7 | Details |
| AChE/BChE-IN-9 | C20H19N3O4 | 2761542-55-4 | Details |
| DPP-4 inhibitor 3 | C19H22N6O2 | 2402735-14-0 | Details |
| EGFR-IN-68 | C24H22N2O | 2416925-03-4 | Details |
| ARN1468 | C16H17F3N4O2 | 1381459-14-8 | Details |
| CA224 | C24H22N2O | 883561-04-4 | Details |
| HFI-419 | C19H18N2O5 | 1110650-72-0 | Details |
| ZLD2218 | C22H18N4O | 2713974-32-2 | Details |
| CDK1/Cyc B-IN-1 | C14H12ClN3O2S2 | 2459916-56-2 | Details |
| 5-HT6/5-HT2A receptor ligand-2 | C20H18FN3O2 | 2411088-16-7 | Details |
| hCAIX-IN-6 | C18H12N2O4S | 2451479-86-8 | Details |
| Anticancer agent 74 | C25H21NO | 2242503-82-6 | Details |
| MRGPRX4 modulator-2 | C15H9ClF4O3 | 2492595-24-9 | Details |
| MIF-IN-5 | C18H14FN5O2 | 2582755-31-3 | Details |
| R-PSOP | C20H22N4O2 | 1185189-97-2 | Details |
| Irdabisant hydrochloride | C18H24ClN3O2 | 1005398-61-7 | Details |
| PDE4-IN-11 | C21H19FN2O2 | 524734-30-3 | Details |
| Stemphyperylenol | C20H16O6 | 102694-33-7 | Details |
| Aβ-IN-5 | C21H20N2O3 | 2417977-65-0 | Details |
| Cdc7-IN-8 | C19H21N5O2 | 2606780-38-3 | Details |
| 5-HT6/5-HT2A receptor ligand-1 | C21H19FN2O2 | 2411088-07-6 | Details |
| EGFR-IN-64 | C20H21N3O3 | 2416924-93-9 | Details |
| TRK-IN-16 | C19H20FN5O | 1365212-81-2 | Details |
| COX-1/2-IN-1 | C15H10BrClN2O | 2358849-47-3 | Details |
| Cdc7-IN-19 | C19H21N5O2 | 2606780-39-4 | Details |
| Antileishmanial agent-3 | C14H13ClN6O4 | 2755930-28-8 | Details |
| Antibacterial agent 97 | C19H23N5S | 1714961-61-1 | Details |
| TRK-IN-15 | C19H20FN5O | 1365213-20-2 | Details |
| Tubulin inhibitor 12 | C24H20N2O | 92575-00-3 | Details |
| hDHODH-IN-9 | C21H21NO4 | 133676-47-8 | Details |
| mGluR2 modulator 4 | C18H18BrN3 | 2582758-47-0 | Details |
| F-17 | C17H15BrO4 | 1572464-22-2 | Details |
| LSD1-IN-14 | C21H24FN5 | 2698340-11-1 | Details |
| CXCR4 antagonist 8 | C21H26N6 | 2304750-84-1 | Details |
| hCAI/II-IN-2 | C12H12N4O5S2 | 2480283-75-6 | Details |
| PPARγ agonist 7 | C20H30O6 | 2569295-93-6 | Details |
| CXCR4 antagonist 5 | C21H30N6 | 2304749-86-6 | Details |
| NAT2-IN-1 | C19H20N4O3 | 856005-97-5 | Details |
| AChE/BChE/BACE-1-IN-1 | C19H21F3N2O | 1321361-13-0 | Details |
| MAT2A-IN-5 | C17H12ClF3N2O | 2756458-55-4 | Details |
| Antiparasitic agent-7 | C18H15N3O5 | 2253996-75-5 | Details |
| Antituberculosis agent-1 | C21H21NO4 | 2411740-98-0 | Details |
| CBR-6672 | C17H20FN3O2S | 2225885-40-3 | Details |
| hCAXII-IN-1 | C20H17NO5 | 2451479-66-4 | Details |
| Antiparasitic agent-8 | C17H22FN3O4 | 2538594-33-9 | Details |
| Antitumor agent-57 | C20H15NO5 | 2432823-48-6 | Details |
| BET-IN-7 | C18H12ClN3OS | 303985-05-9 | Details |
| COX-2-IN-19 | C18H18N4O2S | 2497530-12-6 | Details |
| Anti-osteoporosis agent-1 | C20H19ClN2O2 | 2761577-50-6 | Details |
| Cdc7-IN-13 | C18H20N4O2S | 2764866-23-9 | Details |
| Plasma kallikrein-IN-3 | C20H23N5O2 | 1357950-47-0 | Details |
| LmCPB-IN-1 | C18H30N6O2 | 2151025-98-6 | Details |
| Orbofiban | C17H23N5O4 | 163250-90-6 | Details |
| JAK-2/3-IN-2 | C19H19ClN2OS | 2170398-48-6 | Details |
| D18 | C21H28N6 | 2230218-36-5 | Details |
| 3-(3-Phenoxybenzyl)amino-β-carboline | C24H19N3O | 1327080-54-5 | Details |
| Anti-inflammatory agent 17 | C20H23NO5 | 2763226-84-0 | Details |
| Product Total： Product Page： | ||||
| 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 | ||||